Advertisement

The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristics

Abstract

Aims and background. High mammographic breast density (MBD) is an established risk factor for breast cancer (BC). The influence of diet and physical activity (PA) on MBD has long been investigated. In an observational study of a cohort in Florence, we observed inverse associations between consumption of vegetables and olive oil and moderate leisure-time PA and MBD, while high alcohol intake and high glycemic load diets were positively associated with MBD. We set out to investigate whether dietary and PA interventions were able to reduce MBD in postmenopausal women with high MBD (>50%).
Methods and study design. The DAMA (Diet, physical Activity and MAmmography) trial, a factorial randomized trial involving healthy nonsmoking postmenopausal women not using hormone replacement therapy and having MBD >50%, is aimed at evaluating the ability of a 24-month intervention based on moderate-intensity PA and/or dietary modification focused on plant foods with a low glycemic load, low in saturated fats and alcohol, and rich in antioxidants and fiber, to reduce the percent MBD. Participants have been randomized to 1 of 4 study arms (diet, PA, diet + PA, control). Dietary and PA habits and anthropometry are collected at baseline and at the end of the intervention phase together with repeated blood and urine samples. The primary outcome of the study is the absolute change in percent MBD as assessed on baseline and follow-up digital mammograms performed in the framework of the local screening program.
Results. Of 728 eligible women, 234 (32.1%) agreed to participate. We did not observe any difference across study arms in the baseline distribution of variables of interest related to diet and lifestyle.
Conclusions. The DAMA trial may contribute to a better understanding of MBD determinants. This will provide insight into the pathogenesis of BC and may allow the development of strategies for primary prevention focused on high-MBD groups that are easily identifiable in large-scale BC screening programs.
Trial Registration Number: ISRCTN28492718.

Tumori 2014; 100(4): 377 - 385

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1636.17890

Authors

Giovanna Masala, Melania Assedi, Saverio Caini, Ilaria Ermini, Daniela Occhini, Maria Castaldo, Benedetta Bendinelli, Donatella Zagni, Donata Tanzini, Calogero Saieva, Daniela Ambrogetti, Domenico Palli

Article History

This article is available as full text PDF.

Download any of the following attachments:

Authors

  • Masala, Giovanna [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Assedi, Melania [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Caini, Saverio [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Ermini, Ilaria [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Occhini, Daniela [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Castaldo, Maria [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Bendinelli, Benedetta [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Zagni, Donatella [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Tanzini, Donata [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Saieva, Calogero [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Ambrogetti, Daniela [PubMed] [Google Scholar]
    Cancer Screening Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy
  • Palli, Domenico [PubMed] [Google Scholar]
    Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.